Table 2.

N-cadherin expression in transitional cell carcinoma of the bladder according to the pathologic stage and E-cadherin expression status

Clinical stageN-cadherin-positive expression
pT110 (14%)
    E-cadherin positive8 (80%)
    E-cadherin negative2 (20%)
pT2-T318 (60%)
    E-cadherin positive7 (39%)
    E-cadherin negative11 (61%)